Evolent Health Inc Cl A Com (EVH)

$4.18 +0.02 (0.48%)
Market Cap 522.92M
Revenue (ttm) 2.55B
Net Income (ttm) -61.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2.41%
Debt to Equity Ratio 1.25
Volume 6,199,303
Avg Vol 3,342,692
Day's Range N/A - N/A
Shares Out 117.51M
Stochastic %K 1%
Beta 0.58
Analysts Strong Sell
Price Target $13.92

Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system tha...

Industry: Health Information Services
Sector: Healthcare
Phone: 571 389 6000
Address:
1812 N. Moore Street, Suite 1705, Arlington, United States
anachartanalyst
anachartanalyst Nov. 14 at 6:04 PM
$EVH https://anachart.com/wp-content/uploads/ana_temp/1763143434_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 5:41 PM
Canaccord Genuity has updated their rating for Evolent Health ( $EVH ) to Buy with a price target of 9.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Nov. 14 at 5:16 PM
$EVH Big money if we see $5.00 again I have a good feeling on this bounce🚨🚨
0 · Reply
mp1514
mp1514 Nov. 14 at 4:29 PM
$EVH I think a lot people got this one wrong but management didn’t help. They are not very transparent but now they are starting to be better. A little late tho. They tricked a lot of people very good traders and hedge fund managers. The next 2 years look good according to that last meeting at the UBS. I’m actually glad they got rid of John Johnson as the CFO. Hopefully the new guy will be more forthcoming with information moving forward to gain back trust by shareholders. Next 2 years should be cash flow positive moving forward and the debt should be handled by late 2027 according to the meeting.
0 · Reply
Goosisloose
Goosisloose Nov. 14 at 4:11 PM
$EVH So is this a victim of miscalculations in health utilization or is this just mismanagement, I can wait if there is hope, but very ugly right now.
0 · Reply
profitusp
profitusp Nov. 14 at 4:05 PM
$EVH it is crazy cheap
0 · Reply
mp1514
mp1514 Nov. 14 at 3:57 PM
$EVH Management needs to buy shares it’s been bleeding heavy since September
0 · Reply
PHILMYWALLET
PHILMYWALLET Nov. 14 at 3:44 PM
$EVH if there is no insider buying at this low price, it means they are no faith in the company, so why should we or institutions act differently?
0 · Reply
BPler
BPler Nov. 14 at 3:28 PM
$EVH Anyone with an updated DD here? I entered at double digits and added for months, the upside potential seems to be bigger know than months before.
1 · Reply
TOMKiLA
TOMKiLA Nov. 14 at 12:23 PM
$EVH so, evolent health is showing good news with strong increase of revenues and 75m new ebidtda next year and the market say “it’s okay so down again”! Maybe the problem is the increase of costs but this is unbelievable cause we are talking about 1.8b revenues this year and 2.5/2.7 b next year with a market cap of 400m $?! Hahaha love it, I will buy shares
1 · Reply
Latest News on EVH
Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 11, 2025, 10:21 PM EST - 2 days ago

Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript

Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 2:46 PM EST - 7 days ago

Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

Nov 6, 2025, 4:12 PM EST - 8 days ago

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

Evolent Announces Third Quarter 2025 Results

Nov 6, 2025, 4:10 PM EST - 8 days ago

Evolent Announces Third Quarter 2025 Results

Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Oct 9, 2025, 8:30 AM EDT - 5 weeks ago

Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners

Sep 23, 2025, 4:10 PM EDT - 7 weeks ago

Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners

PRVA

Evolent's Soft Q2 Results: Why I'm Holding Anyway

Aug 21, 2025, 8:35 AM EDT - 3 months ago

Evolent's Soft Q2 Results: Why I'm Holding Anyway

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Aug 19, 2025, 7:00 AM EDT - 3 months ago

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Aug 18, 2025, 4:05 PM EDT - 3 months ago

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 6:15 PM EDT - 3 months ago

Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript

Evolent Announces Second Quarter 2025 Results

Aug 7, 2025, 4:10 PM EDT - 3 months ago

Evolent Announces Second Quarter 2025 Results

Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Jul 14, 2025, 8:00 AM EDT - 4 months ago

Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Evolent announces key appointments to leadership team

Jul 9, 2025, 8:00 AM EDT - 4 months ago

Evolent announces key appointments to leadership team

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

Jun 20, 2025, 6:30 AM EDT - 5 months ago

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript

May 9, 2025, 6:03 PM EDT - 6 months ago

Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript

Evolent Announces First Quarter 2025 Results

May 8, 2025, 4:10 PM EDT - 6 months ago

Evolent Announces First Quarter 2025 Results

Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors

Apr 22, 2025, 6:30 AM EDT - 7 months ago

Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors

Evolent program achieves 20% reduction in use of low-value oncology regimens

Apr 15, 2025, 9:00 AM EDT - 7 months ago

Evolent program achieves 20% reduction in use of low-value oncology regimens

Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025

Apr 10, 2025, 5:00 PM EDT - 7 months ago

Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025

Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 7:28 PM EST - 9 months ago

Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript

Evolent Announces Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:10 PM EST - 9 months ago

Evolent Announces Fourth Quarter and Full Year 2024 Results

Evolent Health Announces Changes to Board of Directors

Feb 4, 2025, 7:00 AM EST - 10 months ago

Evolent Health Announces Changes to Board of Directors

Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

Jan 27, 2025, 5:00 PM EST - 10 months ago

Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1

Dec 18, 2024, 4:10 PM EST - 11 months ago

Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1

Evolent Health: A Shot At Revival After Market Bruising

Nov 12, 2024, 2:37 AM EST - 1 year ago

Evolent Health: A Shot At Revival After Market Bruising

Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:12 AM EST - 1 year ago

Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Nov 8, 2024, 8:47 AM EST - 1 year ago

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session

PINS RDFN SG

Evolent Announces Third Quarter 2024 Results

Nov 7, 2024, 4:10 PM EST - 1 year ago

Evolent Announces Third Quarter 2024 Results

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Oct 11, 2024, 8:00 AM EDT - 1 year ago

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 1 year ago

Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2

Evolent Health: Let The Bidding Begin

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Evolent Health: Let The Bidding Begin

Exclusive: Evolent Health in sale talks after inbound interest, sources say

Aug 22, 2024, 1:22 PM EDT - 1 year ago

Exclusive: Evolent Health in sale talks after inbound interest, sources say

Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 9:18 PM EDT - 1 year ago

Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript

Evolent Announces Second Quarter 2024 Results

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Evolent Announces Second Quarter 2024 Results

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 11, 2024, 8:00 AM EDT - 1 year ago

Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify

Jun 4, 2024, 7:00 AM EDT - 1 year ago

Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.

May 9, 2024, 4:15 PM EDT - 1 year ago

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.

Evolent Announces First Quarter 2024 Results

May 9, 2024, 4:10 PM EDT - 1 year ago

Evolent Announces First Quarter 2024 Results

Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024

Apr 18, 2024, 4:30 PM EDT - 1 year ago

Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024

Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 10:34 PM EST - 1 year ago

Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript

Evolent Announces Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 4:10 PM EST - 1 year ago

Evolent Announces Fourth Quarter and Full Year 2023 Results

Evolent Adds Russell Glass, Headspace CEO, to Board of Directors

Feb 14, 2024, 4:10 PM EST - 1 year ago

Evolent Adds Russell Glass, Headspace CEO, to Board of Directors

Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024

Jan 25, 2024, 7:00 AM EST - 1 year ago

Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Dec 5, 2023, 10:59 PM EST - 2 years ago

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Dec 5, 2023, 7:00 AM EST - 2 years ago

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript

Nov 4, 2023, 3:13 AM EDT - 2 years ago

Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript

Evolent Announces Third Quarter 2023 Results

Nov 2, 2023, 4:10 PM EDT - 2 years ago

Evolent Announces Third Quarter 2023 Results

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences

Oct 10, 2023, 5:30 PM EDT - 2 years ago

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences

A First Evaluation On Evolent Health

Oct 4, 2023, 3:16 PM EDT - 2 years ago

A First Evaluation On Evolent Health

Evolent saves Medicare more than $55 million through its Medicare Shared Savings Program ACO

Aug 24, 2023, 5:21 PM EDT - 2 years ago

Evolent saves Medicare more than $55 million through its Medicare Shared Savings Program ACO

anachartanalyst
anachartanalyst Nov. 14 at 6:04 PM
$EVH https://anachart.com/wp-content/uploads/ana_temp/1763143434_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 5:41 PM
Canaccord Genuity has updated their rating for Evolent Health ( $EVH ) to Buy with a price target of 9.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Nov. 14 at 5:16 PM
$EVH Big money if we see $5.00 again I have a good feeling on this bounce🚨🚨
0 · Reply
mp1514
mp1514 Nov. 14 at 4:29 PM
$EVH I think a lot people got this one wrong but management didn’t help. They are not very transparent but now they are starting to be better. A little late tho. They tricked a lot of people very good traders and hedge fund managers. The next 2 years look good according to that last meeting at the UBS. I’m actually glad they got rid of John Johnson as the CFO. Hopefully the new guy will be more forthcoming with information moving forward to gain back trust by shareholders. Next 2 years should be cash flow positive moving forward and the debt should be handled by late 2027 according to the meeting.
0 · Reply
Goosisloose
Goosisloose Nov. 14 at 4:11 PM
$EVH So is this a victim of miscalculations in health utilization or is this just mismanagement, I can wait if there is hope, but very ugly right now.
0 · Reply
profitusp
profitusp Nov. 14 at 4:05 PM
$EVH it is crazy cheap
0 · Reply
mp1514
mp1514 Nov. 14 at 3:57 PM
$EVH Management needs to buy shares it’s been bleeding heavy since September
0 · Reply
PHILMYWALLET
PHILMYWALLET Nov. 14 at 3:44 PM
$EVH if there is no insider buying at this low price, it means they are no faith in the company, so why should we or institutions act differently?
0 · Reply
BPler
BPler Nov. 14 at 3:28 PM
$EVH Anyone with an updated DD here? I entered at double digits and added for months, the upside potential seems to be bigger know than months before.
1 · Reply
TOMKiLA
TOMKiLA Nov. 14 at 12:23 PM
$EVH so, evolent health is showing good news with strong increase of revenues and 75m new ebidtda next year and the market say “it’s okay so down again”! Maybe the problem is the increase of costs but this is unbelievable cause we are talking about 1.8b revenues this year and 2.5/2.7 b next year with a market cap of 400m $?! Hahaha love it, I will buy shares
1 · Reply
RunnerSignals
RunnerSignals Nov. 13 at 9:40 PM
$HUMA $EVH $VYGR $CAPR $BTDR and more have massive upside potential 🚀 which one will sprint first Bottom line https://stocksrunner.com/news/2025-11-13-stock-upgrades-today-see-wall-street-boost-confidence
0 · Reply
PHILMYWALLET
PHILMYWALLET Nov. 13 at 7:37 PM
$EVH https://www.tipranks.com/news/ratings/evolent-health-positioned-for-growth-with-strong-fundamentals-and-valuation-upside-ratings?mod=mw_quote_news
1 · Reply
PHILMYWALLET
PHILMYWALLET Nov. 13 at 2:50 PM
$EVH I'm just waiting for the mega squeeze
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Nov. 13 at 2:44 PM
$EVH No dump at open only a pop... I'd love to see $5.00 or more🌞🌞🌞🌞
0 · Reply
ThePain
ThePain Nov. 13 at 2:20 PM
$EVH ready for dump at open :) ssr has no affect
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:48 AM
BMO Capital has updated their rating for Evolent Health ( $EVH ) to Outperform with a price target of 7.
0 · Reply
Arcides
Arcides Nov. 13 at 3:50 AM
$EVH -66% last year, -60% YTD...going to zero.
1 · Reply
ThePain
ThePain Nov. 12 at 10:06 PM
$EVH I smell a buyout
3 · Reply
ThePain
ThePain Nov. 12 at 9:56 PM
$EVH darkpool shorting 650k :) 150% is near
1 · Reply
BPler
BPler Nov. 12 at 9:24 PM
$EVH Okay, I'm in for the short squeeze now, aswell.
0 · Reply
profitusp
profitusp Nov. 12 at 7:28 PM
$EVH big opportunnity as price does not make any sense🥳🎉
0 · Reply
mp1514
mp1514 Nov. 12 at 7:18 PM
$EVH Now you understand why I said fire the whole board. They are worthless. Unless I’m missing something then I will apologize but I don’t see them doing any positive for this company anymore. I’m out!!!
1 · Reply